JAMA Network
About the Study: In this multisite cohort of 346 adults receiving Oregon's state-regulated psilocybin services, serious adverse reactions were uncommon, and most participants reported improvements in depression, anxiety, PTSD symptoms, well-being, and life satisfaction. The longitudinal findings suggest that Oregon's regulated psilocybin services were generally safe and associated with improved mental health outcomes.
Meeting Information
This paper is being presented at the Oregon Psychedelic Innovation Summit.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
